Apple (AAPL) Stock Price Declined While Saratoga Research & Investment Management Upped Position; Asset Management Group Raised Pfizer (PFE) Holding by $313,298

Pfizer Inc. (NYSE:PFE) Logo

Saratoga Research & Investment Management increased its stake in Apple Inc (AAPL) by 3.74% based on its latest 2018Q4 regulatory filing with the SEC. Saratoga Research & Investment Management bought 20,043 shares as the company’s stock declined 2.81% while stock markets rallied. The institutional investor held 555,802 shares of the computer manufacturing company at the end of 2018Q4, valued at $87.67M, up from 535,759 at the end of the previous reported quarter. Saratoga Research & Investment Management who had been investing in Apple Inc for a number of months, seems to be bullish on the $877.61 billion market cap company. The stock increased 1.30% or $2.39 during the last trading session, reaching $186.12. About 39.04 million shares traded or 12.59% up from the average. Apple Inc. (NASDAQ:AAPL) has risen 0.49% since March 17, 2018 and is uptrending. It has underperformed by 3.88% the S&P500. Some Historical AAPL News: 10/05/2018 – Apple Is Said to Pick Goldman Sachs to Issue Reward Credit Card; 17/04/2018 – Regina Leader: Apple planning a news subscription service similar to Apple Music; 02/05/2018 – Apple rose 4.4 percent after reporting better-than-expected quarterly earnings and revenue that surpassed market expectations; 04/05/2018 – @BeckyQuick JUST IN: Apple CEO Tim Cook comments to CNBC about Berkshire Hathaway’s stake in the tech giant; 27/03/2018 – Apple’s education event: Live notes There’s a new iPad. And more; 09/05/2018 – Alphabet, Apple and Microsoft will be part of government drone pilots, but Amazon was left out; 31/05/2018 – FOCUS-Sony’s push into entertainment aims for stability, not splashiness; 17/05/2018 – NH HOTELS NHH.MC – ANNOUNCES STRATEGIC ALLIANCE WITH APPLE LEISURE GROUP TO JOINTLY OPERATE BEACHFRONT RESORTS IN EUROPE; 04/04/2018 – Ottawa Citizen: Apple working on curved iPhone screens, touchless gesture control; 07/03/2018 – China’s Apple Trade Would Keep Doctor Away for 164 Million Years

Asset Management Group Inc increased its stake in Pfizer Inc (PFE) by 19.67% based on its latest 2018Q4 regulatory filing with the SEC. Asset Management Group Inc bought 7,286 shares as the company’s stock declined 4.08% while stock markets rallied. The institutional investor held 44,328 shares of the health care company at the end of 2018Q4, valued at $1.94 million, up from 37,042 at the end of the previous reported quarter. Asset Management Group Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $231.95B market cap company. The stock increased 1.43% or $0.59 during the last trading session, reaching $41.78. About 70.94 million shares traded or 160.80% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 17, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 16/04/2018 – AstraZeneca Presents lmfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting; 20/04/2018 – P&G’s vitamin boost could signal more to come; 10/04/2018 – PFIZER JOINS TRINETX GLOBAL HEALTH RESEARCH NETWORK FORMED TO I; 22/03/2018 – GSK advances in Pfizer consumer health auction as Reckitt quits; 08/03/2018 – Cellectis: Servier and Pfizer Announce Results of UCART19 First-in-Human Trials to Be Presented at the 44th EBMT (European; 21/03/2018 – RECKITT BENCKISER GROUP PLC RB.L – CO’S PROPOSAL WAS FOR PART OF THE BUSINESS ONLY; 21/03/2018 – Britain’s use of copycat biotech drugs takes off while U.S. lags; 29/03/2018 – Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy; 17/04/2018 – Biovica International AB: Positive results with DiviTum® from new Pfizer study presented at the AACR congress; 23/03/2018 – GSK pullout puts sale of Pfizer consumer health unit in doubt

Investors sentiment increased to 0.97 in Q4 2018. Its up 0.30, from 0.67 in 2018Q3. It increased, as 82 investors sold AAPL shares while 860 reduced holdings. 159 funds opened positions while 756 raised stakes. 2.83 billion shares or 5.50% more from 2.68 billion shares in 2018Q3 were reported. Allstate has invested 1.89% in Apple Inc. (NASDAQ:AAPL). D E Shaw & Inc holds 1.14% in Apple Inc. (NASDAQ:AAPL) or 5.25M shares. Bnp Paribas Arbitrage reported 1.81M shares. Mar Vista Invest Ptnrs Limited Liability Com holds 3.32% or 626,364 shares in its portfolio. Linscomb And Williams reported 0.63% in Apple Inc. (NASDAQ:AAPL). Frontier Inv Management holds 318,353 shares. Smithbridge Asset De has invested 3.94% in Apple Inc. (NASDAQ:AAPL). Moreover, Atalanta Sosnoff Ltd Liability has 3.18% invested in Apple Inc. (NASDAQ:AAPL). Meeder Asset Management holds 2.35% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 167,205 shares. Solutions Ltd holds 0.01% in Apple Inc. (NASDAQ:AAPL) or 479 shares. Moreover, Scotia Cap has 2.33% invested in Apple Inc. (NASDAQ:AAPL) for 816,551 shares. Pnc Services stated it has 8.50 million shares or 1.49% of all its holdings. Delta Capital Mngmt Ltd Liability holds 38,578 shares. State Farm Mutual Automobile Com has 1.98% invested in Apple Inc. (NASDAQ:AAPL). Cornerstone invested in 16,645 shares or 0.47% of the stock.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Seekingalpha.com which released: “Apple: Large Dividend Raise Coming? – Seeking Alpha” on March 13, 2019, also Nasdaq.com with their article: “Technology Sector Update for 02/26/2019: WSTG, SPNS, ATHM, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” published on February 26, 2019, Seekingalpha.com published: “Qualcomm launches new Apple patent challenge – Seeking Alpha” on March 04, 2019. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Seekingalpha.com and their article: “Apple: Stress-Valuation – Seeking Alpha” published on February 25, 2019 as well as Seekingalpha.com‘s news article titled: “Qualcomm argues against Apple’s patent workaround – Seeking Alpha” with publication date: February 19, 2019.

Since November 19, 2018, it had 0 insider buys, and 2 insider sales for $902,607 activity. KONDO CHRIS sold $647,520 worth of stock.

Saratoga Research & Investment Management, which manages about $1.40B and $1.26 billion US Long portfolio, decreased its stake in Omnicom Group (NYSE:OMC) by 7,592 shares to 139,939 shares, valued at $10.25 million in 2018Q4, according to the filing. It also reduced its holding in C.H. Robinson Worldwide (NASDAQ:CHRW) by 30,901 shares in the quarter, leaving it with 614,160 shares, and cut its stake in Oracle (NYSE:ORCL).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Investorplace.com which released: “The Case Against Pfizer Stock and the Rest of the Industry – Investorplace.com” on March 15, 2019, also Seekingalpha.com with their article: “FDA OKs Pfizer’s Herceptin biosimilar – Seeking Alpha” published on March 12, 2019, Seekingalpha.com published: “Pfizer in-licenses diabetes candidate from AnTolRx – Seeking Alpha” on March 05, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Teva launches generic Flector Patch in U.S. – Seeking Alpha” published on March 01, 2019 as well as Seekingalpha.com‘s news article titled: “Study links Pfizer’s Celebrex to heart valve problems – Seeking Alpha” with publication date: February 25, 2019.

Asset Management Group Inc, which manages about $284.95M and $243.51M US Long portfolio, decreased its stake in Vanguard Bond Index Fund Intermediate Te (BIV) by 7,430 shares to 16,664 shares, valued at $1.36 million in 2018Q4, according to the filing. It also reduced its holding in Invesco Ny Muni Amt Free Mun Bd Etf (PZT) by 36,773 shares in the quarter, leaving it with 9,978 shares, and cut its stake in Pimco Active Bond Etf (BOND).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart